semaglutide litigation A 76-year-old woman’s wrongful death claim has now become part of the growing Ozempic and GLP-1 litigation., Her family alleges that Ozempic caused severe gastroparesis, also known as stomach Ozempic® Lawsuit | July 2026

The Wegovy protocol, the FDA-approved formulation for weight loss, uses this progression: 0.25mg for weeks 1 through 4, 0.5mg for weeks 5 through 8, 1.0mg for weeks 9 through 12, 1.7mg for weeks 13 through 16, and finally 2.4mg from week 17 onward

Semaglutide is an FDA-approved injectable medication designed to help obese adults lose weight and maintain it

In addition to regulating blood sugar, the medication acts on the brains appetite centers

Although many patient enjoy weight loss with few to no side effects, GI discomfort including heartburn, nausea, constipation, diarrhea, & bloating are the most common side effects

These conditions are commonly seen in patients with hidradenitis suppurativa (HS)